Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Toxic Substances and Health
 
Report Contents
 
Charge to the Panel
Panel Members
 
Fate & Biomonitoring
 
Sampling Methodologies
Health Endpoints
Susceptible Populations
Exposure Evaluation
Biomonitoring
 
Correlation of Data
 
Risk Management
 
Relocation Criteria
 
Reference Doses
 
Decontamination
 
Recommendations
 
Clinical Evaluation
 
Appropriate Triggers
Health Status
Environmental Medicine
 
Evaluation Protocol
 
Standardizing Lab Data
Treatment
Neurobehavioral Effects
Acute Poisoning
Suggested Evaluation
 
Overarching Issues
 
Recommendations
Field Survey
7-day Study
Dermal Absorption
Subchronic Toxicity
Pilot Study
Cohort Study
 
Selected References
 
Risk Communication
 
Workgroup
Recommendations
Operating Procedures
Management & Planning
Limitations of Strategies
Planning Steps
Identifying Populations
Preventing Exposures
Research Needs
Conclusions
 
Risk Documents
 
Cancer Policy
Risk Assessment
Communication Primer
Evaluation Primer
Psychologial Responses
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
HazDat Database
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry
Methyl Parathion Expert Panel Report

April 24-25, 1997
Atlanta, Georgia


Note: While the original publication dates on some of ATSDR's documents may not appear to be current, the information in the documents is valid and may still provide relevant information.


Charge to the Expert Panel

The Agency for Toxic Substances and Disease Registry (ATSDR) convened an expert panel workshop on April 24 and 25, 1997, in Atlanta, Georgia, to discuss issues related to illegal spraying of the pesticide methyl parathion (MP) in residences. The purpose of the expert panel was to assist ATSDR, the U.S. Environmental Protection Agency (EPA), and state and local health departments in addressing key issues of science, public health practice, and risk management related to this indoor use of methyl parathion. The panel was asked to address a set of key issues raised by the governmental interagency Methyl Parathion Health Sciences Steering Committee (hereafter, the steering committee).

The expert panel decided to address these issues in two separate work groups: Risk Identification/Management and Public Health Practice. The Public Health Practice Work Group further subdivided their tasks into Health Education/Risk Communication and Clinical Practice. The Risk Identification/Management Work Group was chaired by Daniel Hryhorczuk, MD, MPH, and comprised Janice Chambers, PhD, Jim Riviere, DVM, PhD, Stanley Shuman, MD, PhD, and Sheldon Wagner, MD. The Public Health Practice Work Group was chaired by Caron Chess, MS. Members of the Health Education/Risk Communication subgroup were Ms. Chess and Luz Claudio, PhD. Members of the Clinical Practice subgroup were Mike O'Malley, MD, MPH, and Victor Roth, MD, MPH. This report includes the advice and of the individual work groups as well as advice and on overarching issues between the work groups that were addressed by the expert panel in plenary session. The panel also identified critical data gaps and knowledge needs that must be addressed to develop science-based risk management decisions.

The opinions and put forth by the panel are based on a time-limited review of materials and data that were presented to the panel by organizers and observers, as well as on our personal expertise and experience. These opinions and are not based on a critical review of all available scientific literature on these topics or a thorough review of all available field data collected by these agencies. For those reasons, we believe that the opinions and in this report should be continually re-examined and action plans updated as new or previously unreviewed data become available. Also, the panel was asked to focus specifically on MP and did not address the issue of combined exposures to multiple pesticides or other environmental toxins. The panel acknowledges that concurrent exposures to other agents may occur; such exposures should be considered in site-specific risk management.


Panel Members

  • Daniel O. Hryhorczuk, MD, MPH (Chair)
  • Caron Chess, MS (Chair of Public Health Practice Workgroup)
  • Janice E. Chambers, PhD
  • Luz Claudio, PhD
  • Mike A. O'Malley, MD, MPH
  • Jim E. Riviere, DVM, PhD
  • Victor S. Roth, MD, MPH
  • Stanley Schuman, MD, PhD
  • Sheldon Wagner, MD

Top of Page